HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06,health professional,use report with the FDA on 2015-06-11 for HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+ manufactured by International Technidyne Corp..

Event Text Entries

[5944812] Healthcare professional reported excessive bleeding while using hemochron signature elite and act+ system to monitor anticoagulation status using intravenous heparin during a procedure. An (b)(6) kg pt of unspecified age and gender was undergoing a vascular procedure on an unspecified leg. Over the course of the procedure that lasted more than 3 hrs, act+ test results increased accordingly during incremental heparin dosing. Near the end of the procedure excessive bleeding occurred, initially treated with fresh frozen plasma and finally protamine to reverse the effects of heparin. The act result fell to normal levels and bleeding was controlled. No serious adverse events or other medical complications were reported. Both electronic and liquid quality control testing passed prior to the procedure. System malfunction is not suspected.
Patient Sequence No: 1, Text Type: D, B5


[13485819] This mdr submitted on 06/10/2015 references itc complaint #(b)(4). The associated homochron signature elite instrument used during the procedure is referenced by itc complaint #(b)(4). The most likely cause for this patient's bleeding was the administration of an excessive amount of heparin. This may have been compounded by an undocumented anti-thrombin-iii deficiency. The use of this jact+ test, which is not optimized for low heparin concentrations, may have contributed to how the anticoagulation management was conducted during the procedure. Itc has requested all data required for form 3500a.
Patient Sequence No: 1, Text Type: N, H10


[76161842] Mdr follow-up #1 references (b)(4), and summarizes the results of lsr-030 that evaluated a device from the same lot of jact+ cuvettes.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2248721-2015-00045
MDR Report Key4843723
Report Source05,06,HEALTH PROFESSIONAL,USE
Date Received2015-06-11
Date of Report2015-05-19
Date of Event2015-05-19
Date Mfgr Received2015-05-19
Device Manufacturer Date2015-04-01
Date Added to Maude2015-06-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street8 OLSEN AVE.
Manufacturer CityEDISON NJ 08820
Manufacturer CountryUS
Manufacturer Postal08820
Manufacturer Phone8582632490
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST
Generic NameTEST, TIME, ACTIVATED CLOTTING TIME
Product CodeJBP
Date Received2015-06-11
Model NumberJACT+
Catalog NumberJACT+
Lot NumberD5JAC089
Device Expiration Date2016-07-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINTERNATIONAL TECHNIDYNE CORP.
Manufacturer AddressEDISON NJ 08820 US 08820


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2015-06-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.